Search research articles
Contact Us
Filters
Showing results (131-140 of 188) with videos related to
Page
of 19
Sort By:
International Journal of Immunopharmacology
|
January 1, 1993
In vitro combined effects of human interferons and interleukin-2 on natural cell-mediated cytotoxicity
M P Fuggetta, A Aquino, R Pepponi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 15, 1998
Role of wild-type p53 on the antineoplastic activity of temozolomide alone or combined with inhibitors of poly(ADP-ribose) polymerase
L Tentori, P M Lacal, E Benincasa, et al.
International Journal of Cancer
|
January 15, 1983
Modulation of natural killer (nk) cell activity during FLV-P virus infection of mice
G Migliorati, T Jezzi, L Frati, et al.
International Journal of Cancer
|
May 28, 1992
Comparative anti-viral and anti-proliferative activity of PGA1 and PGJ2 against HTLV-I-infected MT-2 cells
C D'Onofrio, C Amici, A Puglianiello, et al.
International Journal of Cancer
|
July 15, 1987
In vitro susceptibility of different human T-cell subpopulations and resistance of large granular lymphocytes to HTLV-I infection
B Macchi, M Popovic, P Allavena, et al.
Pharmacological Research
|
September 1, 1992
O6-alkylguanine-DNA alkyltransferase activity in blasts obtained from patients with myelogenous or lymphocytic leukemia
S D'Atri, G Papa, V Tuorto, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 24, 1999
O(6)-benzylguanine enhances the in vitro immunotoxic activity of temozolomide on natural or antigen-dependent immunity
E Alvino, R Pepponi, E Pagani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 1999
Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines
S Sigala, I Faraoni, D Botticini, et al.
Leukemia
|
February 20, 1999
In vitro infection of CD4+ T lymphocytes with HTLV-I generates immortalized cell lines coexpressing lymphoid and myeloid cell markers
M Tricarico, B Macchi, S D'Atri, et al.
International Journal of Immunopharmacology
|
July 1, 1994
Untreated or drug-treated tumor cells are differentially recognized by allogeneic lymphocytes
S D'Atri, L Romani, E Bonmassar, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 188) with videos related to
Sort By:
Page
of 19
International Journal of Immunopharmacology
|
January 1, 1993
In vitro combined effects of human interferons and interleukin-2 on natural cell-mediated cytotoxicity
M P Fuggetta, A Aquino, R Pepponi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 15, 1998
Role of wild-type p53 on the antineoplastic activity of temozolomide alone or combined with inhibitors of poly(ADP-ribose) polymerase
L Tentori, P M Lacal, E Benincasa, et al.
International Journal of Cancer
|
January 15, 1983
Modulation of natural killer (nk) cell activity during FLV-P virus infection of mice
G Migliorati, T Jezzi, L Frati, et al.
International Journal of Cancer
|
May 28, 1992
Comparative anti-viral and anti-proliferative activity of PGA1 and PGJ2 against HTLV-I-infected MT-2 cells
C D'Onofrio, C Amici, A Puglianiello, et al.
International Journal of Cancer
|
July 15, 1987
In vitro susceptibility of different human T-cell subpopulations and resistance of large granular lymphocytes to HTLV-I infection
B Macchi, M Popovic, P Allavena, et al.
Pharmacological Research
|
September 1, 1992
O6-alkylguanine-DNA alkyltransferase activity in blasts obtained from patients with myelogenous or lymphocytic leukemia
S D'Atri, G Papa, V Tuorto, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 24, 1999
O(6)-benzylguanine enhances the in vitro immunotoxic activity of temozolomide on natural or antigen-dependent immunity
E Alvino, R Pepponi, E Pagani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 1999
Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines
S Sigala, I Faraoni, D Botticini, et al.
Leukemia
|
February 20, 1999
In vitro infection of CD4+ T lymphocytes with HTLV-I generates immortalized cell lines coexpressing lymphoid and myeloid cell markers
M Tricarico, B Macchi, S D'Atri, et al.
International Journal of Immunopharmacology
|
July 1, 1994
Untreated or drug-treated tumor cells are differentially recognized by allogeneic lymphocytes
S D'Atri, L Romani, E Bonmassar, et al.
Page
of 19